FOXO1 decreases glucose oxidation rate through enhancing pyruvate dehydrogenase kinase 4 (PDK4) expression and thus impairs right ventricular function in pulmonary hypertension in rats.13 Here, PDK4 is linked to pulmonary arterial hypertension.